AstraZeneca’s Cancer Drug Trial Disappoints, Sending Shares Lower
LONDON — AstraZeneca announced on Thursday that a cancer drug in development had not shown as much progress as expected, a setback ...
LONDON — AstraZeneca announced on Thursday that a cancer drug in development had not shown as much progress as expected, a setback ...